HRGN — Harvard Apparatus Regenerative Technology Balance Sheet
0.000.00%
- $41.81m
- $42.04m
- $0.10m
Annual balance sheet for Harvard Apparatus Regenerative Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.913 | 1.03 | 1.24 | 1.24 | 0.432 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0.077 | 0 | — | 0.004 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.41 | 1.68 | 1.59 | 1.59 | 0.783 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.585 | 0.399 | 0.279 | 0.196 | 0.073 |
Other Long Term Assets | |||||
Total Assets | 1.99 | 2.08 | 1.87 | 2.4 | 2.61 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.814 | 0.756 | 4.84 | 1.36 | 0.968 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.903 | 0.951 | 4.89 | 1.41 | 0.968 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1.09 | 1.13 | -3.03 | 0.989 | 1.65 |
Total Liabilities & Shareholders' Equity | 1.99 | 2.08 | 1.87 | 2.4 | 2.61 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |